Partner Headlines - ICPT

  1. Intercept Pharma Spikes On Report That It’s Exploring A Sale

    IBD
  2. Intercept Pharmaceuticals Soars 30%; Reuters Reported Company ...

    Benzinga
  3. Benzinga's Top Upgrades

    Benzinga
  4. BioMarin, Intercept hit by FDA

    IBD
  5. BioMarin, Intercept Pharma Drugs Face FDA Delays

    IBD
  6. INTERCEPT PHARMA

    IBD
  7. Intercept Pharma Higher On Takeover Rumor

    Benzinga
  8. Intercept Presents New Data Analyses on Non-Invasive Liver Testing ...

    Benzinga
  9. Intercept Presents New Primary Biliary Cholangitis Data at AASLD ...

    Benzinga
  10. Benzinga's M&A Chatter for Tuesday November 10, 2015

    Benzinga
  11. Intercept Pharmaceuticals

    IBD
  12. Intercept Pharmaceuticals Rebounds After Phase 2 Trial Of OCA ...

    Benzinga
  13. Intercept Pharma NASH Drug Disappoints In Japan

    IBD
  14. Mid-Morning Market Update: Markets Open Higher; Hershey Earnings ...

    Benzinga
  15. Morning Market Losers

    Benzinga
  16. Mid-Morning Market Update: Markets Open Lower; Carlyle Group ...

    Benzinga
  17. Morning Market Gainers

    Benzinga
  18. FDA Grants Priority Review for Intercept's Obeticholic Acid for ...

    Benzinga
  19. CNBC's Meg Tirrel Speculates About Gilead's New Acquisiton

    Benzinga
  20. Sportsman's Warehouse, Bob Evans, Peabody Energy Lead Tuesday's ...

    Benzinga
  21. Benzinga's Top Initiations

    Benzinga
  22. Barclays Initiates Intercept Pharmaceuticals With Overweight

    Benzinga
  23. Intercept Pharmaceuticals Inc (ICPT) Moves Forward With OCA REGENERATE ...

    GuruFocus
  24. Intercept has a design for test

    IBD
  25. Intercept's NASH Trial Design Irks Investors

    IBD
  26. Will The Bulls In Options Continue To Be Disappointed This Week?

    Benzinga
  27. Analysts are Positive on Intercept Pharmaceuticals Inc Following ...

    GuruFocus
  28. Earnings Scheduled For March 2, 2015

    Benzinga
  29. Making Money With Charles Payne: 02/06/15

    FoxBusiness
  30. Wedbush Highlights 2015 Catalysts for Emerging BioPharmaceuticals ...

    GuruFocus
  31. Cowen And Company Analyst Explains Why Intercept Pharmaceuticals ...

    Benzinga
  32. Cowen Analyst Likes Intercept Pharmaceuticals, ACADIA Pharmaceuticals ...

    Benzinga
  33. Mid-Afternoon Market Update: Crude Oil Jumps 7.5%; Visa Shares ...

    Benzinga
  34. Intercept Pharmaceuticals Soars 20%, Possible Short Squeeze

    Benzinga
  35. Mid-Day Market Update: Amazon Jumps On Upbeat Earnings; Hawaiian ...

    Benzinga
  36. Intercept Pharmaceuticals (ICPT) Obeticholic Acid Momentum, Gigamon ...

    GuruFocus
  37. Benzinga's Volume Movers

    Benzinga
  38. Mid-Morning Market Update: Markets Drop; Mastercard Profit Tops ...

    Benzinga
  39. Morning Market Gainers

    Benzinga
  40. Friday Morning Movers: Amazon Pops, Deckers Outdoor Plummets ...

    Benzinga
  41. Stock Futures Sharpen Losses; Amazon, Visa, MasterCard Climb

    IBD
  42. Benzinga's Top #PreMarket Gainers

    Benzinga
  43. INTERCEPT PHARMACEUTICALS

    IBD
  44. Deutsche Bank: No Big Move In FY15 For Intercept Pharmaceuticals

    Benzinga
  45. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  46. Gilead Acquires Drug Program For Fatty Liver Disease

    IBD
  47. IPO Stock Watch: FibroGen Up With Liver-Disease Field

    IBD
  48. Making Money With Charles Payne: 12/22/14

    FoxBusiness
  49. Intercept Announces Publication Of Meta-Analysis From The Global ...

    Benzinga
  50. Here Are The Top 25 Analysts On Wall Street

    Benzinga
  51. Stock Movers: Why Medicals Issues Are Dipping Today

    IBD
  52. Mid-Afternoon Market Update: Lions Gate Surges On Earnings Beat; ...

    Benzinga
  53. Midday Losers From November 7: Roka Bioscience, Salix Pharmaceuticals, ...

    Benzinga
  54. Morning Market Losers

    Benzinga
  55. Benzinga's Top #PreMarket Losers

    Benzinga
  56. Meet The 5 Companies Loving Obamacare

    Benzinga
  57. Morning Market Losers

    Benzinga
  58. Benzinga's Top #PreMarket Losers

    Benzinga
  59. Benzinga's Top Initiations

    Benzinga
  60. Cowen Initiates Intercept At Outperform

    Benzinga
  61. Four biotech takeover targets?

    IBD
  62. 4 Biotechs That Might Be Bought Soon

    IBD
  63. InterMune Stock Spikes On Rare Big Biotech Buyout

    IBD
  64. Morning Market Losers

    Benzinga
  65. Benzinga's Top #PreMarket Losers

    Benzinga
  66. CNBC's Stock Pops & Drops From August 12

    Benzinga
  67. Markets Marginally Lower In Quiet Trading Session

    Benzinga
  68. U.S. Job Openings Climb; Leerink Swann Bullish On Intercept Pharmaceuticals

    Benzinga
  69. U.S. Stocks Fall; Dealertrack Shares Surge On Upbeat Results

    Benzinga
  70. Markets Mostly Flat; Flowers Foods Profit Misses Estimates

    Benzinga
  71. Stocks Stake Out Thin Gains; Intercept, Insys, Autohome Gain

    IBD
  72. Intercept Pharma Soars On Liver-Disease Drug Data

    IBD
  73. Benzinga's Volume Movers

    Benzinga
  74. Morning Market Movers

    Benzinga
  75. Conatus Shares Move Higher On Industry Data

    Benzinga
  76. Stock Futures Hem And Haw; Intercept Pharmaceuticals Soars

    IBD
  77. Benzinga's Top #PreMarket Gainers

    Benzinga
  78. Intercept Pharma Soars On Positive Liver Drug Data

    IBD
  79. INTERCEPT PHARMACEUTICALS

    IBD
  80. Intercept Pharmaceutical's Shares Soar On Earnings

    Benzinga
  81. Steven Cohen Has a Track Record of Impressive Returns

    GuruFocus
  82. Intercept Pharmaceutical Shares Up Amid Deutsche Bank Initiation

    Benzinga
  83. Markets Little Changed Ahead Of 4th Of July Break

    Benzinga
  84. Benzinga's Top Initiations

    Benzinga
  85. Analysts Comment On Intercept Amid Share Decline Following FLINT ...

    Benzinga
  86. Top Healthcare Movers For June 9, 2014

    Benzinga
  87. Market Wrap For April 14: Markets Surge on Positive Retail Data, ...

    Benzinga
  88. Weekly CFO Sells Highlight: Intercept Pharmaceuticals Inc., ...

    GuruFocus
  89. Intercept Issues Preclinical Data Showing OCA's Potential Role ...

    Benzinga
  90. US Stock Futures Nudge Higher Ahead Of Jobs Data

    Benzinga
  91. Market Wrap For March 17: Investors Focused On Economic Data ...

    Benzinga
  92. Intercept Pharmaceuticals Announces Q4 Earnings

    Benzinga
  93. Stocks Near Session Highs; Kandi Up 26% On Q4 Results

    IBD
  94. Top Trending Tickers On StockTwits For March 17

    Benzinga
  95. Benzinga's Top #PreMarket Losers

    Benzinga
  96. Morning Gainers for Friday, March 14, 2014

    Benzinga
  97. Biotech ETFs Flash Buy Signals (XBI, IBB, BBH, ICPT)

    Benzinga
  98. Shares of Intercept Pharma Rise as BofA Sees US, EU Regulators ...

    Benzinga
  99. Fatty Liver Disease Should Keep Stocks Moving In 2014

    IBD
  100. Precious Metals, Health Care Led Mutual Funds In Feb.

    IBD
Trading Center